Publications 2009 - 2012

PUBLICATIONS 2009-2012

 

Prof  Deirdre McNamara

  1. Holleran G, Barry S, Thornton O, Dobson M, McNamara D. The use of small bowel capsule endoscopy in iron deficiency anaemia: low impact on outcome in the medium term despite high diagnostic yield. European Journal of Gastroenterology and Hepatology, 2012
  2. Leen R, Seng-Lee, McNamara D. Reduction in sequential FIT positivity and cancer detection rates in the Tallaght-Trinity College colorectal cancer screening programme (TTC-CRC-SP) over time. Gastroenterology, American Gastroenterological Association, USA, May 2012, 142, (5), 2012, ppS156-
  3. Holleran G, Barry S, Thornton O, Dobson M, McNamara D. Low long term predictive value of SBCE despite high diagnostic yield in Iron deficiency anaemia. Gastroenterology, American Gastroenterological Association, USA, May, 2012, 142, (5), 2012, ppS-807-
  4. Holleran G, Shearer N, O'Morain C, McNamara D. The high frequency of adenomas detected on screening in older patients warrants the inclusion of this cohort in national programmes. Gastroenterology, American Gastroenterological Association, USA, May, 2012, 142, (5), 2012, ppS-776-
  5. Leen R, Thornton O, Dobson M, O’Morain C, McNamara D. Preliminary results of capsule colonoscopy as a filter test prior to standard optical colonoscopy in a FIT positive screening cohort. GUT, United European Gastroenterology Week, Amsterdam, October 2012, 61, 2012, ppA300-
  6. Lee C.S, Shailesh A, McMahon B, McNamara D. A novel technique for measurement of ileo-ceacal valve function. GUT, United European Gastroenterology Week, Amsterdam, October 2012, 61, 2012, ppA305-
  7. Leen R, Shearer N, O’Morain C, McNamara D. Faecal M2-Pyruvate kinase in screening for colorectal polyps and cancer. GUT, United European Gastroenterology Week, Amsterdam, October 2012, 61, 2012, ppA181-
  8. Lee CS, Leen R, O'Morain C, McNamara D. Screening for colorectal cancer: What fits best?  Expert Reviews Gastroenterology Hepatology, 6, (3), 2012, p301 – 312
  9. Lee CS, McNamara D, O'Morain C, Aspirin as a Chemoprevention Agent for Colorectal CancerCurrent Drug Metabolism,2012
  10. El-Sherif O, Breslin N, O'Connor H, Ryan B, O'Morain C, McNamara D, The efficacy of various faecal immunological test (FIT) cut-off points in a two step bowel cancer screening programme. GUT, United European Gastroenterology Week , 2011, 60, 2, 2011, ppA202
  11. McNamara D, Qasim A, Lee N, Condon C, O'Morain C, Round one of the Adelaide and Meath Hospital/Trinity College Colorectal Cancer Screening Programme: programme report and analysis based on established international key performance indices. Irish journal of medical science, 180, (2), 2011, p549 – 542
  12. Macdonald J, Porter-Ritchie V, Mackie B, McNamara D. Assessment of tolerance, safety and efficacy of ambulatory oesophageal pH monitoring using the catheter free Bravo system in a Scottish population. GUT, British Society of Gastroenterology , 2011, 60, (1), 2011, ppA182-
  13. Anthony O’Connor, Javier P. Gisbert, McNamara D. Colm O’Morain, Treatment of Helicobacter pylori Infection 2011, Helicobacter, 16, (s1), 2011, p53–58
  14. Lee CS, O’Gorman P, Walsh P, Qasim A, McNamara D, O’Morain C, Boran G., Immunochemical faecal occult blood tests have superior stability.Journal of Clinical Pathology,64, (6), 2011, p524 – 528
  15. Alakarri A, El-Sheriff O, Dobson M, Thornton O, McNamara D. Is focused training adequate or is prior upper and lower gastrointestinal endoscopy experience needed for reliable reporting of capsule endoscopy, Endoscopy, United European Gastroenterology Week, 2011, 43, (SI), 2011, ppA343-
  16. Macdonald J, Porter V, Scott NW, McNamara D, Small bowel lymphangiectasia and angiodysplasia: a positive association; novel clinical marker or shared pathophysiology?Journal of clinical gastroenterology, 44, (9), 2010, p610-4
  17. Macdonald JC, Porter V, Mackie B, McNamara D. Do we overestimate the risk of capsule endoscopy in suspected or established small bowel Crohn's disease? A comparison with completion rates observed in the setting of obscure gastrointestinal bleeding. GUT, United European Gastroenterology Week, 2010, 59, (1), 2010, ppA53-
  18. Macdonald JC, Ramalingam S, Porter-Ritchie V, Thomson J, Yule S, McNamara D. A prospective comparison of MR enterography and wireless capsule endoscopy for assessment of small bowel Crohn’s disease. Interim assessment. Endoscopy, 18th United European Gastroenterology Week, 2010, 42, (Supl I), 2010, ppA277-
  19. O'Connor A, Gisbert JP, McNamara D, O'Morain C, Treatment of Helicobacter pylori infection 2010. Helicobacter, 15 Suppl 1, 2010, p46-52
  20. Porter V, McDonald J, Mackie B, McNamara D. Accuracy of 13C Mixed Triglyceride Breath Testing for investigation of exocrine pancreatic insufficiency- an audit. GUT, United European Gastroenterology Week, 2010, 59, (SIII), 2010, ppA441-
  21. McLeman L, Sinclair T, McNamara D. Colonoscopy performance in the colon cancer screening era: Does equipment matter.  Gastroenterology Today , 3, (19), 2009, p80-83
  22. Porter V, Zahid A, Mackie B, McNamara D. Results of a prospective comparison pilot validation study of a low dose tablet formulation 13C Urea and Citric acid Breath Test employing a novel automated non dispersive isotope selective infrared spectroscopy analyzer (HeliFAN/ FAN as) for the diagnosis of Helicobacter pylori infection. European Journal of Gastroenterology, 21, (11), 2009, p1321 - 1322

 

Dr Niall Breslin

  1. Nadarajan P, Sulaiman I, Kent B, Breslin N, Moloney ED, Lane SJ. Endoscopic ultrasound with fine needle aspiration and biopsy in lung cancer and isolated mediastinal lymphadenopathy.  Ir Med J. 2010 Mar;103(3):75-7.
  2. Duggan S, Egan SM, Smyth ND, Feehan SM, Breslin N, Conlon KC.  Blind bedside insertion of small bowel feeding tubes.Ir J Med Sci. 2009 Dec;178(4):485-9.
  3. O'Connor JP, O'Moráin CA, Neary P, Breslin NP.  Use of Infliximab as rescue therapy in acute severe Ulcerative Colitis with recent norovirus infection. J Crohns Colitis. 2009 Sep;3(3):204-6. Epub 2009 May 8

 

Prof Humphrey O’Connor

  1. Alakkari A, Zullo A, O'Connor HJ. Helicobacter pylori and nonmalignant diseasesHelicobacter. 2011 Sep;16 Suppl 1:33-7. doi: 10.1111/j.1523-5378.2011.00878.x. Review
  2. Saleem A, Qasim A, O'Connor HJ, O'Morain CA. Pylera for the eradication of Helicobacter pylori infection.Expert Rev Anti Infect Ther. 2009 Sep;7(7):793-9. Review.
  3. Qasim A, O'Morain CA, O'Connor HJ.  Helicobacter pylori eradication: role of individual therapy constituents and therapy duration. Fundam Clin Pharmacol. 2009 Feb;23(1):43-52. Epub 2009 Jan 10. Review.
  4. Canavan JB, Bennett K, Feely J, O'Moráin CA, O'Connor HJ. Significant psychological morbidity occurs in irritable bowel syndrome: a case-control study using a pharmacy reimbursement database.    Aliment Pharmacol Ther. 2009 Feb 15;29(4):440-9. Epub 2008 Nov 14
  5. Taneike I, Nami A, O'Connor A, Fitzgerald N, Murphy P, Qasim A, O'Connor H, O'Morain C. Analysis of drug resistance and virulence-factor genotype of Irish Helicobacter pylori strains: is there any relationship between resistance to metronidazole and cagA status?  Aliment Pharmacol Ther. 2009 Oct;30(7):784-90. Epub 2009 Jul 9

 

DEPARTMENT  PUBLICATIONS  2009 -2012

 

  1. O'Connor A, Alakkari A, Ryan B, Breslin N, McNamara D, O'Connor HJ, O'Morain C. Age, smoking, male gender and regular aspirin use predict premalignant conditions of the stomach in a low risk gastric cancer prevalence cohort. Gastroenterology, American Gastroenterological Association, USA, May, 2012, 142, (5), 2012, ppS-633-
  2. O'Connor A, Alakkari A, McNamara D, Breslin N, Ryan B, O'Connor H, O'Morain C. Departmental attitudes for the awareness and prevention of gastric cancer prevent missed diagnoses. Helicobacter, XXIV International Workshop on Helicobacter and related bacteria in chronic digestive inflammation and gastric cancer., 2011, 16, (S1), 2011, pp92 – 93
  3. O’Connor A, El-Sherif O, McNamara D, Ryan B, Breslin N, Shearer N, O’Connor H, O’Morain C. 2-sample Faecal Immunological Test based screening is superior to 1-sample screening for the detection of colonic adenomata and neoplasia. GUT, United European Gastroenterology , 2011, 60, (S3), 2011, ppA81-
  4. O’Connor A, Alakkari A, McNamara D, Breslin N, Ryan B, O’Connor H, O’Morain C. Surveillance of gastric intestinal metaplasia leads to the earlier stage diagnosis of gastric adenocarcinoma. Helicobacter, XXIV International Workshop on Helicobacter and related bacteria in chronic digestive inflammation and gastric cancer., 2011, 16, (S1), 2011, ppP01.08-
  5. O'Connor A, Keane RA, Egan B, Lee N, O'Connor H, Qasim A, Ryan B, Breslin N, McNamara D, O'Morain C. Adherence to colorectal polyp surveillance guidelines: is there scope to increase the opportunities for screening?European Journal of Cancer Prevention : the official journal of the European Cancer Prevention Organisation (ECP), 20, (1), 2010, p40 – 45
  6. O’Connor A, Alakkari A, McNamara D, Breslin N, Ryan B, O’Connor H, O’Morain C. Resistance to Levofloxacin, Rifabutin and Tetracycline amongst H.pylori strains in a reference centre. Helicobacter, XXIII International Workshop on Helicobacter and related bacteria in chronic digestive inflammation and gastric cancer , 2010, 15, (4), 2010, pp388-
  7. Thornhill JA, Long RM, Neary P, O'Connor HJ, Ryan B, Fraser I. The pitfalls of treating anorectal conditions after radiotherapy for prostate cancer.Ir Med J. 2012 Mar;105(3):91-3
  8. O'Donnell S, Kelly OB, Breslin N, Ryan BM, O'Connor HJ, Swan N, O'Morain CA. Eosinophilic oesophagitis: an Irish experience.Eur J Gastroenterol Hepatol. 2011 Nov;23(12):1116-21.
  9. Qasim A, Ullah N, Crotty P, Swan N, Breslin N, Ryan B, Torreggiani W, Eguare E, Neary P, O'Connor H, O'Morain C. A changing trend in the management of patients with newly diagnosed Crohn's disease.Ir J Med Sci. 2011 Sep;180(3):643-7. Epub 2011 Mar 23
  10. Keane RA, O'Connor A, Ryan B, Breslin N, O'Connor HJ, Qasim A, O'Morain C. Inappropriate colonoscopic surveillance of hyperplastic polyps.Ir Med J. 2011 Jul-Aug;104(7):211-4
  11. O'Donnell S, Murphy S, Anwar MM, O'Sullivan M, Breslin N, O'Connor HJ, Ryan BM, O'Morain CA.  Safety of infliximab in 10 years of clinical practice. Eur J Gastroenterol Hepatol. 2011 Jul;23(7):603-6.
  12. Shuhaibar M, Walsh C, Lindsay F, Lee N, Walsh P, O'Gorman P, Boran G, McLoughlin R, Qasim A, Breslin N, Ryan B, O'Connor H, O'Morain C. A comparative study of faecal occult blood kits in a colorectal cancer screening program in a cohort of healthy construction workers. Ir J Med Sci. 2011 Mar;180(1):103-8. Epub 2010 Oct 17
  13. O'Connor A, Taneike I, Nami A, Fitzgerald N, Murphy P, Ryan B, O'Connor H, Qasim A, Breslin N, O'Moráin C.  Helicobacter pylori resistance to metronidazole and clarithromycin in Ireland. Eur J Gastroenterol Hepatol. 2010 Sep;22(9):1123-7.
  14. Qasim A, Ryan B, Breslin N, O'Morain C.  Gastric retention and wireless capsule endoscopy in adults: a modified technique for direct duodenal deploymentGut. 2010 Jul;59(7):1004-5; author reply 1005. No abstract available.
  15. O'Donnell S, Qasim A, Ryan BM, O'Connor HJ, Breslin N, O Morain CA. The role of capsule endoscopy in small bowel Crohn's disease.J Crohns Colitis. 2009 Dec;3(4):282-6. Epub 2009 Aug 27